Soheila Montazersaheb

Tabriz University of Medical Sciences

H指数:26

被引数:2,468

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Synthetic Biology-Driven Innovations in Triple-Negative Breast Cancer: Integrating Engineering Design with Targeted Therapeutics

合成生物学驱动的三阴性乳腺癌创新：整合工程设计与靶向治疗

Journal of Biotechnology

IF3.9

2026-05-020

PRE

Gut microbiota and kidney aging: insights into current research

肠道微生物组与肾脏衰老：当前研究的见解

Nutrition & Metabolism

IF4.1

2025-11-070

Targeting STAT3 Pathway: A Promising Immunotherapeutic Strategy for Triple-Negative Breast Cancer – Current Status and Future Outlooks

靶向STAT3通路：一种治疗三阴性乳腺癌的 promising 免疫治疗策略——当前状况与未来展望

European Journal of Pharmacology

IF4.7

2025-08-200

PRE

Targeting cellular senescence in kidney diseases and aging: A focus on mesenchymal stem cells and their paracrine factors

CELL COMMUNICATION AND SIGNALING

IF8.9

2024-12-181

OAAI

Induction of immunogenic cell death and enhancement of the radiation-induced immunogenicity by chrysin in melanoma cancer cells

SCIENTIFIC REPORTS

IF3.9

2024-10-052

OAAI

The role of the hematopoietic stem/progenitor cells-derived extracellular vesicles in hematopoiesis

造血干/祖细胞来源的细胞外囊泡在造血中的作用

HELIYON

IF3.6

2024-08-012

OAAI

Epstein-Barr virus-encoded BART9 and BART15 miRNAs are elevated in exosomes of cerebrospinal fluid from relapsing-remitting multiple sclerosis patients

CYTOKINE

IF3.7

2024-07-018

OAAI

Investigation the apoptotic effect of silver nanoparticles (Ag-NPs) on MDA-MB 231 breast cancer epithelial cells via signaling pathways

HELIYON

IF3.6

2024-03-015

OAAI

Nanoparticle-based delivery platforms for the enhanced oral delivery of peptides/proteins

用于增强肽/蛋白质口服递送的基于纳米颗粒的递送平台

THERAPEUTIC DELIVERY

IF2.2

2023-12-191

PRE

The effect of nanoparticle coating on biological, chemical and biophysical parameters influencing radiosensitization in nanoparticle-aided radiation therapy

BMC CHEMISTRY

IF4.6

2023-12-116

OAAI

Investigation of L-carnitine effects on CD44+cancer stem cells from MDA-MB-231 breast cancer cell line as anti-cancer therapy

REGENERATIVE THERAPY

IF3.5

2023-12-019

OAAI

Oxidative stress regulation and related metabolic pathways in epithelial-mesenchymal transition of breast cancer stem cells

STEM CELL RESEARCH & THERAPY

IF7.3

2023-11-2821

OAAI

Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds

用于癌症治疗的免疫原性细胞死亡刺激剂: 关注天然化合物

CANCER CELL INTERNATIONAL

IF6

2023-09-1319

OAAI

Magnetic nanoparticle-based hyperthermia: A prospect in cancer stem cell tracking and therapy

LIFE SCIENCES

IF5.1

2023-06-0118

PRE

Multiplex Analysis of Cerebrospinal Fluid and Serum Exosomes MicroRNAs of Untreated Relapsing Remitting Multiple Sclerosis (RRMS) and Proposing Noninvasive Diagnostic Biomarkers

未经治疗的复发缓解型多发性硬化症 (RRMS) 的脑脊液和血清外泌体MicroRNAs的多重分析，并提出无创诊断生物标志物

NEUROMOLECULAR MEDICINE

IF3.9

2023-04-0516

PRE

Modulatory Effect of Vitamin C on Hypoxia Induced Breast Cancer Stem Cells

ADVANCED PHARMACEUTICAL BULLETIN

IF4.1

2023-02-210

OAAI

Recent clinical findings on the role of kinase inhibitors in COVID-19 management

LIFE SCIENCES

IF5.1

2022-10-0113

OAAI

COVID-19 infection: an overview on cytokine storm and related interventions

VIROLOGY JOURNAL

IF3.8

2022-05-26373

OAAI

Evaluation of exosomal non-coding RNAs in cancer using high-throughput sequencing

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2022-01-1533

OAAI

Hepatoprotective effects of sericin on aging-induced liver damage in mice

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

IF3.1

2021-10-047

PREAI

Soheila Montazersaheb

个人简介

教育背景

工作经历

荣誉奖项

研究方向